2006
DOI: 10.1016/j.taap.2006.05.012
|View full text |Cite
|
Sign up to set email alerts
|

Toxicokinetics and biotransformation of 3-(4-methylbenzylidene)camphor in rats after oral administration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
26
0
2

Year Published

2010
2010
2019
2019

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 41 publications
(28 citation statements)
references
References 18 publications
0
26
0
2
Order By: Relevance
“…Recent receptor binding data show a strong preference of 4-MBC for ER␤ (10). So far, it is not known whether there exist bioactive metabolites that might possibly exhibit a different effect spectrum; a carboxylated derivative has recently been identified as the major 4-MBC metabolite in female rats (20).…”
Section: Discussionmentioning
confidence: 99%
“…Recent receptor binding data show a strong preference of 4-MBC for ER␤ (10). So far, it is not known whether there exist bioactive metabolites that might possibly exhibit a different effect spectrum; a carboxylated derivative has recently been identified as the major 4-MBC metabolite in female rats (20).…”
Section: Discussionmentioning
confidence: 99%
“…None of those compounds, except BP1, were found in the fungal culture. In 4-MBC assays, the metabolites identified in rats and humans were 3-(4-carboxybenzylidene)-6-hydroxycamphor (the major metabolite) and 3-(4-carboxybenzylidene) camphor and their respective glucuronide conjugates [64]. As in mammals, phase I and phase II enzymes appear to participate in the degradation of BP3, BP1 and 4-MBC by T. versicolor [44,49].…”
Section: Degradation Pathwaysmentioning
confidence: 98%
“…In einer toxikokinetischen Studie mit oraler Verabreichung erhielten je 3 männli-che und weibliche Sprague-Dawley-Ratten per Schlundsonde einmalig Dosen von 25 oder 250 mg 4-MBC/kg KG, gelöst in Maiskeimöl [3,7]. Untersucht wurden die Metabolisierung von 4-MBC sowie über 96 h die Kinetik von 4-MBC und seinen Metaboliten im Blut sowie deren Ausscheidung mit dem Urin.…”
Section: Untersuchungen An Rattenunclassified
“…An Ratten wurde die Ausscheidung im Urin nur in einer oralen [7], aber nicht in einer dermalen Studie untersucht. Die dermale Absorption bei der Ratte lässt sich aus dem Verhältnis der AUC aus den Studien von Völkel et al [7] und Schauer et al [8] und linearer Dosisextrapolation folgendermaßen ableiten: Dermale Absorption = ∑AUC dermale Studie/∑AUC orale Studie * Dosis oral (mg/kg KG/Tag)/Dosis dermal (mg/kg KG/Tag)* Absorption oral.…”
Section: Dermale Absorption Ratteunclassified